DLH Holdings Corp. (DLHC) is a publicly traded Industrials sector company. As of May 21, 2026, DLHC trades at $5.54 with a market cap of $79.71M and a P/E ratio of 10.75. DLHC moved +0.00% today. Year to date, DLHC is -1.77%; over the trailing twelve months it is +11.00%. Its 52-week range spans $2.72 to $9.58. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces DLHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
DLH Q2 Adjusted EBITDA $5.3M, Free Cash Flow $3.8M Despite 33.5% Revenue Drop: DLH's Q2 revenue dropped 33.5% to $59.3 million due to legacy program transitions, while adjusted EBITDA reached $5.3 million (9.0% margin) and free cash flow totaled $3.8 million. Debt fell to $132.7 million and DLH secured a two-year NIH clinical research support contract extension.
| Metric | Value |
|---|---|
| Price | $5.54 |
| Market Cap | $79.71M |
| P/E Ratio | 10.75 |
| EPS | $0.52 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.58 |
| 52-Week Low | $2.72 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $395.94M |
| Net Income | $7.40M |
| Gross Margin | 0.00% |
1 analysts cover DLHC: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.